BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25526554)

  • 21. Prostate cancer drugs could pose risk to heart health. FDA reviewing safety of anti-hormone treatments due to links with heart disease and diabetes.
    Heart Advis; 2010 Aug; 13(8):5. PubMed ID: 22792575
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostate cancer and androgens.
    Johnson ES
    Lancet; 1987 Apr; 1(8536):814. PubMed ID: 2882226
    [No Abstract]   [Full Text] [Related]  

  • 23. Monitoring androgen replacement therapy: testosterone and prostate safety.
    Morales A
    J Endocrinol Invest; 2005; 28(3 Suppl):122-7. PubMed ID: 16042371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re: Prostate cancer in men using testosterone supplementation. F. D. Gaylis, D. W. Lin, J. M. Ignatoff, C. L. Amling, R. F. Tutrone and D. J. Cosgrove.
    Barqawi AB; Crawford ED
    J Urol; 2006 Apr; 175(4):1572-3; author reply 1573-4. PubMed ID: 16552901
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Prostate cancer in men using testosterone supplementation. F. D. Gaylis, D. W. Lin, J. M. Ignatoff, C. L. Amling, R. F. Tutrone and D. J. Cosgrove.
    Morgentaler A; Rhoden EL; Barqawi AB; Crawford ED
    J Urol; 2006 Apr; 175(4):1572; author reply 1573-4. PubMed ID: 16516047
    [No Abstract]   [Full Text] [Related]  

  • 26. Managing prostate cancer.
    Gillmore R
    Practitioner; 2004 Apr; 248(1657):274-80. PubMed ID: 15114817
    [No Abstract]   [Full Text] [Related]  

  • 27. Testosterone supplementation and prostate cancer, controversies still exist.
    Drewa T; Chłosta P
    Acta Pol Pharm; 2010; 67(5):543-6. PubMed ID: 20873424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry.
    Morales A
    BJU Int; 2011 May; 107(9):1369-73. PubMed ID: 21518230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer after exogenous testosterone treatment for impotence.
    Loughlin KR; Richie JP
    J Urol; 1997 May; 157(5):1845. PubMed ID: 9112543
    [No Abstract]   [Full Text] [Related]  

  • 30. Duration dependent induction of invasive prostatic carcinomas with pharmacological dose of testosterone propionate in rats pretreated with 3,2'-dimethyl-4-aminobiphenyl and development of androgen-independent carcinomas after castration.
    Shirai T; Sano M; Imaida K; Takahashi S; Mori T; Ito N
    Cancer Lett; 1994 Aug; 83(1-2):111-6. PubMed ID: 8062203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone deficiency syndrome: treatment and cancer risk.
    Raynaud JP
    J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):96-105. PubMed ID: 19429438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes.
    Kaplan AL; Hu JC
    Urology; 2013 Aug; 82(2):321-6. PubMed ID: 23706552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone.
    Pollard M; Luckert PH; Schmidt MA
    Prostate; 1982; 3(6):563-8. PubMed ID: 7155989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostatic complications of testosterone replacement therapy.
    Jackson JA; Waxman J; Spiekerman AM
    Arch Intern Med; 1989 Oct; 149(10):2365-6. PubMed ID: 2679476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC; Kirby RS
    Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prostate and hormone replacement therapy].
    Pompeo AC; Damião R; Campos RM; Lopes EJ
    Int Braz J Urol; 2006; 32 Suppl 1():35-8. PubMed ID: 23631040
    [No Abstract]   [Full Text] [Related]  

  • 37. [Androgen replacement therapy and prostate cancer].
    Beuzeboc P; Richaud P
    Prog Urol; 2003 Nov; 13(5 Suppl 2):1276-7. PubMed ID: 15816405
    [No Abstract]   [Full Text] [Related]  

  • 38. Testosterone replacement therapy and prostate risks: where's the beef?
    Morgentaler A
    Can J Urol; 2006 Feb; 13 Suppl 1():40-3. PubMed ID: 16526980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is testosterone a friend or a foe of the prostate?
    Jannini EA; Gravina GL; Morgentaler A; Morales A; Incrocci L; Hellstrom WJ
    J Sex Med; 2011 Apr; 8(4):946-55. PubMed ID: 21457469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Male contraception involving testosterone supplementation: possible increased risks of prostate cancer?
    Schally AV; Comaru-Schally AM
    Lancet; 1987 Feb; 1(8530):448-9. PubMed ID: 2880241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.